Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Promoter Region
40%
Single Nucleotide Polymorphism
40%
Gene
40%
Patient
40%
Regulatory Mechanism
40%
Serositis
20%
Homeostasis
20%
Lipid
20%
Cholesterol
20%
Immune Response
20%
Real Time Polymerase Chain Reaction
20%
Luciferase
20%
Receptor
20%
Luciferase Assay
20%
Gel Mobility Shift Assay
20%
Liver X Receptor
20%
Cell Proliferation Assay
20%
N (2,2,2 Trifluoroethyl) N [4 (2,2,2 Trifluoro 1 Hydroxy 1 Trifluoromethylethyl)phenyl]benzenesulfonamide
20%
3 [3 [[2 Chloro 3 (Trifluoromethyl)benzyl](2 Diphenylethyl)amino]propoxy]phenylacetic Acid
20%
B Cell
20%
Assay
20%
Cells
20%
Biochemistry, Genetics and Molecular Biology
Nested Gene
40%
Promoter Region
40%
Luciferase
40%
Single-Nucleotide Polymorphism
40%
Gene Promoter
40%
Regulatory Mechanism
40%
Homeostasis
20%
Cell Proliferation
20%
Cholesterol
20%
Real-Time Polymerase Chain Reaction
20%
Immune Response
20%
Electrophoretic Mobility Shift Assay
20%
Liver X Receptor
20%
B Cell
20%
Liver X Receptor Alpha
20%
Sample
20%
Lipid
20%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Promoter Region
40%
Single Nucleotide Polymorphism
40%
Gene
40%
Regulatory Mechanism
40%
Real Time Polymerase Chain Reaction
20%
Cell Proliferation
20%
Immune Response
20%
B Cell
20%
Gel Mobility Shift Assay
20%
Inflammation Response
20%
Homeostasis
20%
Sample
20%
Cells
20%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Lipid
20%
Luciferase
20%
Cholesterol
20%
Receptor
20%
Liver X Receptor
20%
Electrophoretic Mobility Shift Assay
20%
3 [3 [[2 Chloro 3 (Trifluoromethyl)benzyl](2 Diphenylethyl)amino]propoxy]phenylacetic Acid
20%
N (2,2,2 Trifluoroethyl) N [4 (2,2,2 Trifluoro 1 Hydroxy 1 Trifluoromethylethyl)phenyl]benzenesulfonamide
20%
Liver X Receptor Alpha
20%